Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
Public ClinicalTrials.gov record NCT02410356. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (Genotropin(R)) in Adults With Growth Hormone-Deficiency
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study assesses the safety and tolerability of weekly TV-1106 compared to daily rhGH in adults with GHD who have previously been treated with rhGH.
Study identification
- NCT ID
- NCT02410356
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 34 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2015 (Actual)
- Primary completion
- Feb 29, 2016 (Actual)
- Completion
- Apr 30, 2016 (Actual)
- Last update posted
- Dec 10, 2021
2015 – 2016
United States locations
- U.S. sites
- 32
- U.S. states
- 12
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Teva Investigational Site 13137 | Artesia | California | 90701 | — |
| Teva Investigational Site 13166 | Fountain Valley | California | 33155-6541 | — |
| Teva Investigational Site 13165 | Lakewood | California | 90712 | — |
| Teva Investigational Site 13155 | Denver | Colorado | 80209 | — |
| Teva Investigational Site 13158 | Newark | Delaware | 19713 | — |
| Teva Investigational Site 13162 | Fort Lauderdale | Florida | 33312 | — |
| Teva Investigational Site 13136 | Homestead | Florida | 33030 | — |
| Teva Investigational Site 13138 | Miami | Florida | 33126 | — |
| Teva Investigational Site 13152 | Miami | Florida | 33130 | — |
| Teva Investigational Site 13161 | Miami | Florida | 33145 | — |
| Teva Investigational Site 13500 | Miami | Florida | 33155-6541 | — |
| Teva Investigational Site 13503 | Miami | Florida | 33175 | — |
| Teva Investigational Site 13148 | Miami Lakes | Florida | 33016 | — |
| Teva Investigational Site 13134 | Pembroke Pines | Florida | 33024 | — |
| Teva Investigational Site 13129 | West Palm Beach | Florida | 33401 | — |
| Teva Investigational Site 13135 | Detroit | Michigan | 48202 | — |
| Teva Investigational Site 13146 | Henderson | Nevada | 89052 | — |
| Teva Investigational Site 13147 | Las Vegas | Nevada | 89148 | — |
| Teva Investigational Site 13143 | Brooklyn | New York | 11235 | — |
| Teva Investigational Site 13502 | New York | New York | 10016 | — |
| Teva Investigational Site 13140 | New York | New York | 10032 | — |
| Teva Investigational Site 13128 | Asheville | North Carolina | 28803 | — |
| Teva Investigational Site 13142 | Pittsburgh | Pennsylvania | 15212 | — |
| Teva Investigational Site 13144 | Arlington | Texas | 76014 | — |
| Teva Investigational Site 13163 | Dallas | Texas | 75218 | — |
| Teva Investigational Site 13130 | Houston | Texas | 77079 | — |
| Teva Investigational Site 13141 | Houston | Texas | 77084 | — |
| Teva Investigational Site 13154 | Houston | Texas | 77090 | — |
| Teva Investigational Site 13159 | Norfolk | Virginia | 23507 | — |
| Teva Investigational Site 13504 | Federal Way | Washington | 98003 | — |
| Teva Investigational Site 13164 | Seattle | Washington | 98122 | — |
| Teva Investigational Site 13157 | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 18 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02410356, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 10, 2021 · Synced Oct 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02410356 live on ClinicalTrials.gov.